- The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
-
Kwon HJ, Lee SY, Kim KH, Kim DS, Cha SH, Jo DS, Kang JH
- KMID: 2155475
- J Korean Med Sci.
- 2015 May;30(5):612-616.
- doi: 10.3346/jkms.2015.30.5.612
Effective and tolerable vaccination is an essential strategy to prevent Japanese encephalitis (JE) in endemic areas. Although the live attenuated SA 14-14-2 JE vaccine (LAJEV) has been widely used since... -
- CITED
-
- Close
- SHARE
-
- Close
